Epidemic Trend and Effect of COVID-19 Transmission in India during Lockdown Phase

To evaluate the present situation concerning the epidemic trend associated with the COVID-19 in Indian demography, the dynamics of the case rise has been analyzed from the perspective of the different index. The index for the analysis has been chosen in terms of the Case Recovery Rate (CRR), CASE Fatality Rate (CFR), as well as Mortality rate (MR). The study includes the rise of the case related to the pandemic in the different demographic regions of India as well as deep analysis and calculation of the indexes considered for the study. The analysis of the rising cases has also been investigated to relax the imposed rule so that economy of the country will not get affected adversely. Several preventive and control initiative has been taken by the central and state government in collaboration. The result of this paper can be taken as an input to decide further policy in the fight against the COVID- 19.

A tale of a man, a worm and a snail: the schistosomiasis control initiative

This book contains 21 chapters that describe treatment programs for schistosomiasis and intestinal worms in 16 countries and has helped those countries provide more than 200 million treatments, mainly in schools, to deworm human populations.

The Korea Cancer Big Data Platform (K-CBP) for Cancer Research

Data warehousing is the most important technology to address recent advances in precision medicine. However, a generic clinical data warehouse does not address unstructured and insufficient data. In precision medicine, it is essential to develop a platform that can collect and utilize data. Data were collected from electronic medical records, genomic sequences, tumor biopsy specimens, and national cancer control initiative databases in the National Cancer Center (NCC), Korea. Data were de-identified and stored in a safe and independent space. Unstructured clinical data were standardized and incorporated into cancer registries and linked to cancer genome sequences and tumor biopsy specimens. Finally, national cancer control initiative data from the public domain were independently organized and linked to cancer registries. We constructed a system for integrating and providing various cancer data called the Korea Cancer Big Data Platform (K-CBP). Although the K-CBP could be used for cancer research, the legal and regulatory aspects of data distribution and usage need to be addressed first. Nonetheless, the system will continue collecting data from cancer-related resources that will hopefully facilitate precision-based research.